Interaction of Ritonavir-Boosted Tipranavir with Loperamide Does Not Result in Loperamide-Associated Neurologic Side Effects in Healthy Volunteers von MUKWAYA, Geoffrey, MACGREGOR, Thomas, HOELSCHER, David, HEMING, Thomas, LEGG, Daniel, KAVANAUGH, Kelli, JOHNSON, Phillip, SABO, John P, MCCALLISTER, Scott

Volltext

Pharmacokinetic Interaction between Faldaprevir and Cyclosporine or Tacrolimus in Healthy Volunteers: A Prospective, Open‐Label, Fixed‐Sequence, Crossover Study von Huang, Fenglei, Voelk, Claudia, Trampisch, Matthias, Rowland, Lois, Schultz, Armin, Sabo, John P.

Volltext

Contribution of Major Metabolites toward Complex Drug-Drug Interactions of Deleobuvir: In Vitro Predictions and In Vivo Outcomes von Sane, Rucha S, Ramsden, Diane, Sabo, John P, Cooper, Curtis, Rowland, Lois, Ting, Naitee, Whitcher-Johnstone, Andrea, Tweedie, Donald J

Volltext

Effect of the hepatitis C virus protease inhibitor faldaprevir on the pharmacokinetics of an oral contraceptive containing ethinylestradiol and levonorgestrel in healthy female vol... von Sabo, John P, Lang, Benjamin, Elgadi, Mabrouk, Huang, Fenglei

Volltext

Interaction Studies of Tipranavir-Ritonavir with Clarithromycin, Fluconazole, and Rifabutin in Healthy Volunteers von LA PORTE, Charles J. L, SABO, John P, ELGADI, Mabrouk, CAMERON, D. William

Volltext

Steady-State Disposition of the Nonpeptidic Protease Inhibitor Tipranavir when Coadministered with Ritonavir von LINZHI CHEN, SABO, John P, VALDEZ, Hernan, PHILIP, Elsy, YANPING MAO, NORRIS, Stephen H, MACGREGOR, Thomas R, WRUCK, Jan M, GARFINKEL, Sandra, CASTLES, Mark, BRINKMAN, Amy

Volltext

Mass balance, metabolite profile, and in vitro-in vivo comparison of clearance pathways of deleobuvir, a hepatitis C virus polymerase inhibitor von Chen, Lin-Zhi, Sabo, John P, Philip, Elsy, Rowland, Lois, Mao, Yan, Latli, Bachir, Ramsden, Diane, Mandarino, Debra A, Sane, Rucha S

Volltext

Nevirapine Extended-Release Formulation Tablets in HIV-1–Infected Children—Long-term Follow-up von Anabwani, Gabriel, Königs, Christoph, Giaquinto, Carlos, Aslanyan, Stella, Sabo, John P., Morrow, J.-Scott, Feiterna-Sperling, Cornelia

Volltext

Clinical Assessment of Potential Drug Interactions of Faldaprevir, a Hepatitis C Virus Protease Inhibitor, With Darunavir/Ritonavir, Efavirenz, and Tenofovir von Sabo, John P., Kort, Jens, Ballow, Charles, Haschke, Manuel, Battegay, Manuel, Fuhr, Rainard, Girlich, Birgit, Schobelock, Michael, Feifel, Ulrich, Lang, Benjamin, Li, Yongmei, Elgadi, Mabrouk

Volltext

Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosis von Zeuzem, Stefan, Soriano, Vicente, Asselah, Tarik, Gane, Edward J, Bronowicki, Jean-Pierre, Angus, Peter, Lohse, Ansgar W, Stickel, Felix, Müllhaupt, Beat, Roberts, Stuart, Schuchmann, Marcus, Manns, Michael, Bourlière, Marc, Buti, Maria, Stern, Jerry O, Gallivan, John-Paul, Voss, Florian, Sabo, John P, Böcher, Wulf, Mensa, Federico J

Volltext

Interactions of the hepatitis C virus protease inhibitor faldaprevir with cytochrome P450 enzymes: In vitro and in vivo correlation von Sabo, John P., Kort, Jens, Ballow, Charles, Kashuba, Angela D.M., Haschke, Manuel, Battegay, Manuel, Girlich, Birgit, Ting, Naitee, Lang, Benjamin, Zhang, Wei, Cooper, Curtis, O'Brien, Drané, Seibert, Eleanore, Chan, Tom S., Tweedie, Donald, Li, Yongmei

Volltext

Steady-state Pharmacokinetics of Nevirapine Extended-release Tablets in HIV-1–infected Children and Adolescents: An Open-label, Multiple-dose, Cross-over Study von Giaquinto, Carlo, Anabwani, Gabriel, Feiterna-Sperling, Cornelia, Nuttall, James, Mompati, Kgosidialwa, Königs, Christoph, Mensa, Federico J, Sabo, John P, Yong, Chan-Loi, MacGregor, Thomas R, Nguyen, Thuy, Quinson, Anne-Marie

Volltext

Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone von Bruce, R. Douglas, Altice, Frederick L, Moody, David E, Lin, Shen-Nan, Fang, Wenfang B, Sabo, John P, Wruck, Jan M, Piliero, Peter J, Conner, Carolyn, Andrews, Laurie, Friedland, Gerald H

Volltext

Combined tipranavir and enfuvirtide use associated with higher plasma tipranavir concentrations but not with increased hepatotoxicity : sub-analysis from RESIST von RAFFI, Francois, BATTEGAY, Manuel, RUSCONI, Stefano, OPRAVIL, Milos, BLICK, Gary, STEIGBIGEL, Roy T, KRAFT, Michael, NEUBACHER, Dietmar, SABO, John P

Volltext

Lack of a pharmacokinetic interaction between steady-state tipranavir/ritonavir and single-dose valacyclovir in healthy volunteers von Sabo, John P, Cong, Xiuyu (Julie), Kraft, Michael-Friedrich, Wallace, Lacey, Castles, Mark A, Mauss, Stefan, MacGregor, Thomas R

Volltext

Nevirapine Extended-Release Formulation Tablets in HIV-1–Infected Children—Long-term Follow-up: Table 1 von Anabwani, Gabriel, Königs, Christoph, Giaquinto, Carlos, Aslanyan, Stella, Sabo, John P., Morrow, J.-Scott, Feiterna-Sperling, Cornelia

Volltext

Pharmacokinetic interactions between buprenorphine/naloxone and von Bruce, RDouglas, Altice, Frederick L, Moody, David E, Lin, Shen-Nan, Fang, Wenfang B, Sabo, John P, Wruck, Jan M, Piliero, Peter J, Conner, Carolyn, Andrews, Laurie, Friedland, Gerald H

Volltext

Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteers von Lamson, Michael J., Sabo, John P., Macgregor, Thomas R., Pav, Joseph W., Rowland, Lois, Hawi, Amale, Cappola, Michael, Robinson, Patrick

Volltext

Isotype choice for chimeric antibodies affects binding properties von MORELOCK, M. M, ROTHLEIM, R, WRIGHT, J. L, ADAIR, J. R, BRIGHT, S. M, ROBINSON, M. K, GRAHAM, E. T, SABO, J. P, OWENS, R, KING, D. J, NORRIS, S. H, SCHER, D. S

Volltext

The Effect of Selected Drugs on First-Stage Radioemesis in Beagle Dogs von Gralla, Edward J., Sabo, John P., Hayden, David W., Yochmowitz, Michael G., Mattsson, Joel L.

Volltext